SAME Dobre Apteki Pharmsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-05-29
Share capital
289,000.00 PLN
Registered address
Wallenroda 2F, 20-607 Lublin, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 56 days late).

  • 202519/06/2026
  • 202401/07/2025
  • 202326/06/2024
  • 202211/07/2023
  • 202109/09/2022
  • 202030/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 2.8%
Division · Human health activities437 / 6,273
Top 7.0%
City · Lublin318 / 4,861
Top 6.5%
Voivodeship · Lubelskie857 / 10,225
Top 8.4%
Country · Poland27,553 / 297,935
Top 9.3%

Results vs industry

Revenue
This companyUSD 6.32mMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD 828.77kMedianUSD 14.31kAverageUSD 129.52k
Operating costs
This companyUSD 5.16mMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 7.23mMedianUSD 173.92kAverageUSD 1.02m

National Health Fund (NFZ) contracts

SAME Dobre Apteki Pharm has been an NFZ healthcare provider since 2018. In 2026 it is performing 4 contracts with a total value of USD 575.88k. All its contracts were worth USD 2.02m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Outpatient specialist carelubelskie3USD 410.31k
Psychiatric care and addiction treatmentlubelskie1USD 165.56k

NFZ waiting lists

This company's facilities run 8 NFZ waiting lists. Waiting time forecast by NFZ, as of 10.10.2026.

ServiceWaiting time
Oncological surgery clinic10 days
Addiction treatment clinic14 days
Magnetic resonance imaging20 days
Developmental hip dysplasia clinic24 days
Developmental hip dysplasia clinic1 mo 1 wk

Authorized Representatives

Katarzyna Gargol – President of the Management Board
Wiktoria Gargol – Attorney-in-fact (sole)

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Katarzyna Anna Gargolage 52
1,395$37,682.3348.2699%
Ryszard Zbigniew Gargolage 71
1,495$40,383.5851.7301%

Ryszard Zbigniew Gargol and Katarzyna Anna Gargol hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-07-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

16 public aid cases recorded, with a total value of $62,844.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$891
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,566
De minimis aid (in accordance with Commission Regulation 2023/2831)
$891

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2026-03-19PKD change
2025-08-13PKD change
2018-04-30Name change
2018-04-30PKD change
2015-01-27Share capital increase

FAQ

Last updated: 2026-06-19